Schedule 13G ownership disclosure

Paratek Pharmaceuticals Inc

Security class unavailable · CUSIP: 699374302

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-17-007301
Form type
SC 13G/A
Filer
BAUPOST GROUP LLC/MA
CIK
CIK 1061768
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub